PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
58.07%
Positive growth while CRK shows revenue decline. John Neff would investigate competitive advantages.
-12.02%
Both companies reducing costs. Martin Whitman would check industry efficiency trends.
163.75%
Positive growth while CRK shows decline. John Neff would investigate competitive advantages.
66.85%
Margin expansion while CRK shows decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
-1.04%
Both companies reducing G&A. Martin Whitman would check industry cost trends.
No Data
No Data available this quarter, please select a different quarter.
175.00%
Other expenses growth above 1.5x CRK's 27.57%. Michael Burry would check for concerning trends.
-3.81%
Both companies reducing operating expenses. Martin Whitman would check industry trends.
-7.52%
Both companies reducing total costs. Martin Whitman would check industry trends.
-62.23%
Both companies reducing interest expense. Martin Whitman would check industry trends.
-10.66%
Both companies reducing D&A. Martin Whitman would check industry patterns.
-69.39%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
-80.64%
EBITDA margin decline while CRK shows 59.14% growth. Joel Greenblatt would examine position.
206.96%
Operating income growth while CRK declines. John Neff would investigate advantages.
167.67%
Operating margin growth while CRK declines. John Neff would investigate advantages.
6.68%
Other expenses growth less than half of CRK's 179.76%. David Dodd would verify if advantage is sustainable.
28.14%
Pre-tax income growth while CRK declines. John Neff would investigate advantages.
54.54%
Pre-tax margin growth while CRK declines. John Neff would investigate advantages.
36.57%
Tax expense growth 50-75% of CRK's 57.83%. Bruce Berkowitz would examine efficiency.
23.23%
Net income growth while CRK declines. John Neff would investigate advantages.
51.43%
Net margin growth while CRK declines. John Neff would investigate advantages.
23.20%
EPS growth while CRK declines. John Neff would investigate advantages.
23.41%
Diluted EPS growth while CRK declines. John Neff would investigate advantages.
-0.05%
Share count reduction while CRK shows 0.07% change. Joel Greenblatt would examine strategy.
0.23%
Diluted share reduction below 50% of CRK's 0.07%. Michael Burry would check for concerns.